Nasdaq: TVTX
Travere Therapeutics insiders
The officers, directors and 10% owners of Travere Therapeutics, Inc. who hold the most stock, valued at the live TVTX price.
$48.30
TVTX today −$1.9M (−3.86%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 7
- Their TVTX stock
- $48.1M
- Market value
- $4.64B
- Held by ranked insiders
- 1.04%
Insiders by value of TVTX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Eric M. Dube | CHIEF EXECUTIVE OFFICER | 432,886 | $20.9M | 0.45% | 5011th |
| 2 | Steve Aselage | Director | 146,919 | $7.1M | 0.15% | 10719th |
| 3 | Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | 117,066 | $5.7M | 0.12% | 13290th |
| 4 | Elizabeth E. Reed | Chief Legal Officer and GC | 105,389 | $5.1M | 0.11% | 14278th |
| 5 | Jeffrey A. Meckler | Director | 91,500 | $4.4M | <0.1% | 14186th |
| 6 | Gary A. Lyons | Director | 61,500 | $3.0M | <0.1% | 4752nd |
| 7 | Roy D. Baynes | Director | 41,500 | $2.0M | <0.1% | 10499th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Travere Therapeutics; see each profile for the filing.